GLP-1s - which mimic the effects of the hormone that stimulates insulin release, suppressing glucagon, and slowing gastric ...

Binge eating disorder is strongly associated with weight gain and obesity, though not all individuals with obesity have BED.

A groundbreaking study has revealed that GLP-1 receptor agonists—including popular weight-loss and diabetes drugs like ...

Neuroscientist Sabina Brennan encourages caregivers to live in the moment and notice the happy experiences they share with ...

Key messages • It is known that older people who take more medicines with an anticholinergic effect may be at greater risk of cognitive decline. • There is a lack of high-quality evidence to show ...

Researchers found that the active ingredient in Ozempic may lower the risk of dementia in people with type 2 diabetes.

Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper ...

Results from this study show that there is a direct correlation between the use of anti-obesity medications and testosterone levels,” the study author said.

Ozempic may have serious side effects, including thyroid cancer and problems with the pancreas, gallbladder, kidneys, and eyes. Learn the signs and symptoms.

Popular diabetes and weight loss drug, semaglutide- the active ingredient in 'Wegovy' and 'Ozempic'- may lower dementia risk in people with type 2 diabetes. The corresponding study was published in ...